Remternetug: Alzheimer’s Prevention Trial Enrolls People as Young as 18
There currently no cure or treatment that can completely halt or reverse Alzheimer’s pathology in the brain. One of the biggest obstacles: Even after…
There currently no cure or treatment that can completely halt or reverse Alzheimer’s pathology in the brain. One of the biggest obstacles: Even after…
“During the day he’s completely calm, but at night he gets very agitated.” “Tonight she hasn’t stopped calling out for her mother, who passed…
An expert shares six strategies to help caregivers prevent wandering in dementia during the cold, dark winter season. While wandering in dementia can happen…
Heralded as a longevity treatment for bio-hacking enthusiasts and tech CEOs, therapeutic plasma exchange also has applications for people concerned about inflammatory diseases like…
After months of delays, Alzheon gears up to present data from their pivotal Phase 3 drug trial, while Athira Pharma pays out a settlement…
ApoE4, a genetic variation sometimes referred to as the “Alzheimer’s gene,” is one of the most influential genetic risk factors for developing Alzheimer’s disease….
Your brain can still make new neurons when you’re an adult. But how does the rare birth of these new neurons contribute to cognitive…
A Trump executive order has banned DEI initiatives across the federal government. Scientists say the move could undermine trial diversity and derail the quest…
When Eisai announced in a press release this week that they’d secured FDA approval for an Alzheimer’s drug dosage change, it seemed like a…
In 2023, U.S. Surgeon General Dr. Vivek Murthy sounded the alarm about the social isolation and loneliness epidemic. A recent poll found that three…
Behavioral symptoms of dementia, like agitation, paranoia, depression, and anxiety, can be challenging for caregivers and people living with the disease to navigate. In…
With the 2024 FDA approval of Eli Lilly’s Kisunla for early-stage Alzheimer’s disease, there are now two fairly similar anti-amyloid on the market in…
Two days after President Donald Trump took office, sweeping bans — mostly temporary — went into effect across the U.S. National Institutes of Health…
The way people living with dementia experience the world can change as the disease progresses. Their sense of reality or place in time can…
By 2050, around 135 million people worldwide will be living with dementia. The most common cause of dementia is Alzheimer’s disease. Women are more…